4-HYDROXYTAMOXIFEN
4-HYDROXYTAMOXIFEN Basic information
- Product Name:
- 4-HYDROXYTAMOXIFEN
- Synonyms:
-
- trans-4-Hydroxytamoxifen, (Z)-4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol
- (Z)-3,4-Diphenyl-4-[4-[2-(dimethylamino)ethoxy]phenyl]-3-buten-1-ol
- 2-[4-[(E)-1-(4-Hydroxyphenyl)-2-phenyl-1-butenyl]phenoxy]-N,N-dimethylethanamine
- 4-[(E)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol
- cis-4-Hydroxytamoxifen
- N,N-Dimethyl-2-[4-[(E)-1-(4-hydroxyphenyl)-2-phenyl-1-butenyl]phenoxy]ethanamine
- trans-4-Hydroxytamoxifen
- TAMOXIFEN 4-HYDROXY, (E) AND (Z) ISOMERS (50:50)
- CAS:
- 68047-06-3
- MF:
- C26H29NO2
- MW:
- 387.51
- Product Categories:
-
- Aromatics
- Metabolites & Impurities
- Drug Analogues
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Steroids
- Mol File:
- 68047-06-3.mol
4-HYDROXYTAMOXIFEN Chemical Properties
- Melting point:
- 105-107°C
- Boiling point:
- 513.45°C (rough estimate)
- Density
- 1.1005 (rough estimate)
- refractive index
- 1.6000 (estimate)
- storage temp.
- 2-8°C
- solubility
- 95% ethanol: 20 mg/mL
- form
- powder
- pka
- 10.35±0.15(Predicted)
- color
- white
- Stability:
- Stable. Store cool. Incompatible with strong oxidizing agents.
- InChIKey
- TXUZVZSFRXZGTL-OCEACIFDSA-N
- CAS DataBase Reference
- 68047-06-3
Safety Information
- Hazard Codes
- Xn
- Risk Statements
- 20/21/22-63
- Safety Statements
- 22-23-36
- WGK Germany
- 3
- RTECS
- SL1210000
4-HYDROXYTAMOXIFEN Usage And Synthesis
Chemical Properties
Powder
Uses
A metabolite of Tamoxifen (T006000). A hydroxylated analogue of Tamoxifen with anti-estrogenic properties.
Uses
(Z)-4-Hydroxy Tamoxifen is a metabolite of Tamoxifen (T006000). (Z)-4-Hydroxy Tamoxifen is a hydroxylated analogue of Tamoxifen. (Z)-4-Hydroxy Tamoxifen is a metabolite of Tamoxifen with anti-estrogenic properties.
Uses
tamoxifen metabolite, anti-estrogen, see Tamoxifen 1,01038
Uses
A hydroxylated analogue of tamoxifen with anti-estrogenic properties. A metabolite of Tamoxifen.
Definition
ChEBI: Afimoxifene is a tertiary amino compound that is tamoxifen in which the phenyl group which is in a Z- relationship to the ethyl substituent is hydroxylated at the para- position. It is the active metabolite of tamoxifen. It has a role as an antineoplastic agent, an estrogen receptor antagonist and a metabolite. It is a tertiary amino compound and a member of phenols. It is functionally related to a tamoxifen.
General Description
A cell-permeable, active metabolite of Tamoxifen (Cat. No. 579000) that acts as a potent inhibitor of PKC. It is more potent than the parent compound and inhibits PKC by modifying its catalytic domain. Also available as a 10 mM solution in EtOH (Cat. No. 508225).
Biological Activity
estrogen receptors (er) are members of the superfamily of ligand-modulated nuclear receptors that mediate the actions of steroid hormones, vitamin d, retinoids, and thyroid hormones. er is activated in vivo when bound by naturally occurring estrogens such as 17α-estradiol. in addition to regulating these physiological processes, estrogen also plays a central role in stimulating breast cancer growth. (z)-tamoxifen is a first generation selective er modulators that is currently approved by the fda and is widely used to treat estrogen-dependent breast cancers. its active metabolite, (z)-4-hydroxytamoxifen, is a potent estrogen receptor modulator.
Biochem/physiol Actions
Cell permeable: yes
in vitro
(z)-4-hydroxytamoxifen binds to er with 8-fold higher affinity than tamoxifen. it was found that only the z isomer has the required antiestrogenic activity; the (e)-4-hydroxytamoxifen has only about 5% of its affinity for the er [1].
in vivo
the antioestrogenic activities of (z)-4-hydroxytamoxifen and tamoxifen were determined after oral administration. (z)-4-hydroxytamoxifen was administered to groups of immature rats which also received s.c. injections of 0-2 μg oestradiol. both compounds produced a dose-related decrease in uterine wet weight when compared with the oestradiol-treated controls. at a dose of 1 μg/day, the antiuterotrophic effects of (z)-4-hydroxytamoxifen and tamoxifen were not significantly different but at 5μg/day, (z)-4-hydroxytamoxifen was more active (p < 0.01). (z)-4-hydroxytamoxifen therefore appears to retain its potent antioestrogenic activity after oral administration [2].
storage
-20°C
References
[1] donna d. yu and barry m. forman. simple and efficient production of (z)-4-hydroxytamoxifen, a potent estrogen receptor modulator. j. org. chem. 2003, 68, 9489-9491
[2] jordan vc, collins mm, rowsby l, prestwich g. a monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. j endocrinol. 1977 nov;75(2):305-16.
4-HYDROXYTAMOXIFENSupplier
- Tel
- 17301109980
- sales@hxybio.com
- Tel
- 17622371216
- 799652097@qq.com
- Tel
- 027-59599241 18871490274
- 1400878000@qq.com
- Tel
- 021-58180488
- sales@Medchemleader.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
4-HYDROXYTAMOXIFEN(68047-06-3)Related Product Information
- 3-hydroxytamoxife
- Tamoxifen
- alpha-[4-[2-(dimethylamino)ethoxy]phenyl]-beta-ethyl-alpha-phenylphenethyl alcohol
- 2-[4-[(E)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine
- N-Desmethyl Tamoxifen Methanethiosulfonate
- (E)-4-Acetoxy Tamoxifen
- TAMOXIFEN-N-OXIDE
- desdimethyltamoxifen
- Endoxifen
- (E)-4-Alloxycarboxyl Tamoxifen
- Tamoxifen EP Impurity D
- 4Hydroxy Tamoxifen
- N-Desmethyl-4-hydroxy Tamoxifen β-D-Glucuronide (E/Z Mixture)
- 1-(4-(2-Dimethylamino)-2-ethoxyphenyl butanone
- TaMoxifen DiMer
- 4-Benzyloxy β-Hydroxy TaMoxifen
- Tamoxifen Impurity 3
- N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture)